Scarica l'app Stockscreener
28.24
0.70%
-0.1989
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$28.44
Aprire:
$28.54
Volume 24 ore:
168.50K
Relative Volume:
0.20
Capitalizzazione di mercato:
$12.41B
Reddito:
$5.64B
Utile/perdita netta:
$305.00M
Rapporto P/E:
40.46
EPS:
0.698
Flusso di cassa netto:
-
1 W Prestazione:
-0.70%
1M Prestazione:
+9.25%
6M Prestazione:
+14.70%
1 anno Prestazione:
+12.47%
Intervallo 1D:
$28.13
$28.57
Intervallo di 1 settimana:
$28.02
$28.58
Portata 52W:
$23.69
$31.72
Smith Nephew Plc Adr Stock (SNN) Company Profile
Nome
Smith Nephew Plc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta SNN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
28.23 | 12.41B | 5.64B | 305.00M | 0 | 0.698 |
|
ABT
Abbott Laboratories
|
129.75 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.22 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.60 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.17 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.04 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-03-12 | Downgrade | UBS | Buy → Neutral |
| 2024-11-06 | Downgrade | Berenberg | Buy → Hold |
| 2024-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-07-24 | Iniziato | Deutsche Bank | Buy |
| 2024-06-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-11-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2023-11-03 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-10-31 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2023-10-13 | Iniziato | Stifel | Hold |
| 2023-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2023-04-27 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-04-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | Iniziato | Citigroup | Buy |
| 2022-11-28 | Downgrade | UBS | Neutral → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-07-28 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-04 | Aggiornamento | Redburn | Sell → Neutral |
| 2021-06-09 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | Iniziato | Barclays | Overweight |
| 2020-07-29 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | Downgrade | Citigroup | Buy → Neutral |
| 2019-11-21 | Iniziato | Citigroup | Buy |
| 2019-11-12 | Iniziato | Bernstein | Outperform |
| 2019-07-23 | Aggiornamento | Berenberg | Hold → Buy |
| 2019-02-08 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-12-10 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | Reiterato | Canaccord Genuity | Buy |
| 2018-01-25 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-12-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-27 | Downgrade | Goldman | Buy → Neutral |
| 2017-01-19 | Iniziato | HSBC Securities | Hold |
| 2016-12-08 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | Downgrade | Berenberg | Buy → Hold |
| 2016-02-26 | Iniziato | Cantor Fitzgerald | Hold |
Mostra tutto
Smith Nephew Plc Adr Borsa (SNN) Ultime notizie
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹ - The Globe and Mail
Smith & Nephew plc ADR [SNN] Investment Appeal on the Rise - knoxdaily.com
TRI (Thomson-Reuters Corp) may reap gains as insiders became active recently - knoxdaily.com
Glaukos Corporation (GKOS) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Smith+Nephew reports solid Q1 2025 growth - Investing.com
AN Stock Sees Surge of Approximately 3.05% in Last Five Days - knoxdaily.com
Smith+Nephew schedules Q1 2025 trading report release - Investing.com
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
UBS cuts Smith & Nephew stock rating to Neutral, sets GBP1.25 target - Investing.com
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
SNN (Smith & Nephew plc ADR) may reap gains as insiders became active recently - Knox Daily
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
Goldman Downgrades Riskified Ltd (RSKD) to a Sell from a Neutral - Knox Daily
Smith+Nephew to announce 2024 full year results February 25 - Investing.com
Smith+Nephew appoints new Non-Executive Director - Investing.com
Endoprosthesis Market Size to Surpass USD 60.39 Billion by 2032 at a CAGR of 9.86% - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
Smith & Nephew Sees Challenges in China Market - Morningstar
Smith+Nephew, JointVue partner on ultrasound-based surgical planning for surgical robotics - Mass Device
Smith+Nephew launches new Legion knee system - Mass Device
South Korea Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
The Best Healthcare Stocks to Buy - Morningstar
Smith & Nephew Aligns Director Fees with Shares - TipRanks
China Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Japan Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Smith+Nephew launches Total Ankle patient-matched guides - Mass Device
InfuSystem, Smith+Nephew ink wound therapy distro deal - Mass Device
Smith+Nephew wins FDA nod for hip system compatible with Cori surgical robot - Mass Device
Europe First Aid Market Size & Outlook, 2023-2030 - Grand View Research
Smith+Nephew launches pre-op planning tech for surgical robotics - Mass Device
Healthcare Sector - Morningstar
Here’s Why You Should Invest in Smith & Nephew plc (SNN) - Yahoo Finance
Smith+Nephew rolls out new chronic wound treatment tech - Mass Device
Smith+Nephew sales are up 7% as 12-point plan progresses - Mass Device
Smith+Nephew unveils expanded sports medicine portfolio - Mass Device
Study backs Smith+Nephew Regeneten bioinductive rotator cuff implant - Mass Device
Validea Detailed Fundamental AnalysisSNN - Nasdaq
Smith+Nephew launches hip arthroplasty system in India - Mass Device
Smith+Nephew unveils handheld digital tensioning device for robotic knee surgery - Mass Device
Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Monday, outperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock falls Tuesday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms market despite losses on the day - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Smith Nephew Plc Adr Azioni (SNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):